Recombinant ODC1 anticorps (full length)

N° du produit ABIN7878765

L’anticorps anti-ODC1 Monoclonal Souris est utilisé pour la détection de ODC1 dans des échantillons de Humain. Il a été validé pour WB et ELISA.

Aperçu rapide pour Recombinant ODC1 anticorps (full length) (ABIN7878765)

Antigène: ODC1 (Ornithine Decarboxylase 1 (ODC1))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ODC1 est non-conjugé

Application: Western Blotting (WB), ELISA

Clone: RODC1-487

Détail du produit anti-ODC1 anticorps

Épitope: full length

Fonction: Recombinant Ornithine Decarboxylase Antibody / ODC1

Purification: Protein A/G affinity

Immunogène: Recombinant full-length human protein was used as the immunogen for the recombinant Ornithine Decarboxylase antibody.

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant Ornithine Decarboxylase antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the recombinant Ornithine Decarboxylase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur ODC1

Antigène: ODC1 (Ornithine Decarboxylase 1 (ODC1))

Autre désignation: Ornithine Decarboxylase

Sujet: Recognizes a 51-53 kDa protein, identified as the Ornithine Decarboxylase (ODC-1). ODC is the initial and rate-limiting enzyme in the biosynthetic pathway of polyamines and is involved in the conversion of ornithine to putrescine. The biological activity of ODC-1 is rapidly induced in response to virtually all agents known to promote cell proliferation including hormones, drugs, growth factors, mitogens, and tumor promoters. Reportedly, ODC mRNA levels are elevated in lung carcinomas as well as in colon adenomas and carcinomas. ODC activity in colorectal carcinomas is greater than those in adenomas and normal mucosa.

UniProt: P11926